SCM
ORGO icon

Soleus Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Soleus Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6M Buy
10,140,951
+55,000
+0.5% +$134K 0.85% 33
2026
Q1 		$23.9M Buy
10,085,951
+100,000
+1% +$346K 0.97% 28
2025
Q4 		$51.7M Sell
9,985,951
-2,145,748
-18% -$10.4M 1.91% 13
2025
Q3 		$51.2M Sell
12,131,699
-211,652
-2% -$984K 2.58% 13
2025
Q2 		$45.2M Sell
12,343,351
-135,000
-1% -$503K 2.99% 10
2025
Q1 		$53.9M Sell
12,478,351
-6,525
-0.1% -$26.3K 3.88% 6
2024
Q4 		$40M Buy
12,484,876
+645,000
+5% +$2.16M 2.51% 11
2024
Q3 		$33.9M Buy
11,839,876
+320,922
+3% +$900K 2.62% 11
2024
Q2 		$32.3M Buy
11,518,954
+1,945,756
+20% +$5.22M 2.84% 9
2024
Q1 		$27.2M Buy
9,573,198
+610,198
+7% +$2.07M 2.02% 11
2023
Q4 		$36.7M Sell
8,963,000
-3,333,163
-27% -$9.33M 4.07% 6
2023
Q3 		$39.1M Buy
12,296,163
+568,100
+5% +$1.81M 3.61% 6
2023
Q2 		$38.9M Buy
11,728,063
+1,875,000
+19% +$5.54M 4.33% 5
2023
Q1 		$21M Buy
9,853,063
+2,490,000
+34% +$6.15M 2.17% 10
2022
Q4 		$19.8M Buy
7,363,063
+874,000
+13% +$2.55M 2.84% 10
2022
Q3 		$21M Buy
6,489,063
+1,202,896
+23% +$5.44M 2.86% 12
2022
Q2 		$25.8M Buy
5,286,167
+2,746,000
+108% +$16.9M 4.02% 3
2022
Q1 		$19.4M Buy
2,540,167
+541,080
+27% +$4.19M 2.5% 9
2021
Q4 		$18.5M Buy
1,999,087
+1,359,200
+212% +$14.4M 1.85% 20
2021
Q3 		$9.11M Buy
+639,887
New +$9.94M 1.42% 22

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Soleus Capital Management's ORGO Position: Q2 2026 in Review

Soleus Capital Management increased its Organogenesis Holdings (ORGO) stake by 0.55% in Q2 2026, buying an estimated $134K and bringing the position to 10,140,951 shares worth $24.6M. The position accounts for 0.85% of the portfolio, ranked #33.

Soleus Capital Management first reported a position in ORGO in Q3 2021 and has held it in 20 quarters since. The position peaked at $53.9M in Q1 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Soleus Capital Management held 10,140,951 shares of Organogenesis Holdings worth $24.6M as of Q2 2026.
  • Soleus Capital Management bought 55,000 Organogenesis Holdings shares in Q2 2026, an estimated $134K.
  • Organogenesis Holdings made up 0.85% of Soleus Capital Management's portfolio in Q2 2026, its #33 holding.
  • Soleus Capital Management first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 20 quarters since.
  • Soleus Capital Management's Organogenesis Holdings position peaked at $53.9M in Q1 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.